“Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors”, Clinics, vol. 69, no. 4, pp. 294–303, Apr. 2014, doi: 10.1590/clin.v69i4.79512.